Safety of AH-008 in healthy volunteers
Part of Brain & nervous system, Cancer, Pain clinical trials.
This trial tests a new medicine called AH-008 in healthy people to see if it's safe and how the body processes it. It is a first-in-human study with a single dose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your body mass index (BMI) is between 19 and 32, and you weigh at least 110 pounds (men) or 88 pounds (women).
- You are in good health based on medical history, physical exam, and lab tests.
- You are willing to avoid certain medications, alcohol, and caffeine for a period before and during the study.
- If you are a woman, you must be either past menopause or surgically sterile, or use highly effective birth control.
- If you are a man, you must agree to use condoms or have a sterile partner or be surgically sterile.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This is an early-stage safety study testing a new drug called NHL907 in healthy volunteers. Researchers want to understand how the drug is processed by the body and confirm it is safe.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This study tests a new medicine called HS-20152 in healthy people to see if it is safe and how the body handles it. It is an early-phase trial, so it helps find the right dose and check for side effects.
This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
Hear when a new Chemotherapy-induced Peripheral Neuropathy (CIPN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.